SLC5A2 and diabetes mellitus: For example, in patients with hypertension or diabetes, serial RRI assessments could help identify individuals with subclinical microvascular damage who may benefit from earlier initiation or intensification of cardioprotective therapies (e.g., RAS blockers, SGLT2 inhibitors, GLP-1RAs).